Replies to post #5478 on Halozyme Therapeutics Inc (HALO)

[Fred Kadiddlehopper]

Was the biosimilar a subcu product? If not then the looming threat of biosimilars is exactly what gives HALO the market advantage with all of their partners' products and so it would not be any cause for a sudden price drop, IMHO.
Good luck!
-Fritz